Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure
- 1 April 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 28 (4) , 947-949
- https://doi.org/10.1097/00003246-200004000-00006
Abstract
Objective: The aim of the study was to determine the prognosis in patients who needed norepinephrine treatment in our institution in relation to the degree of organ failure and the evolution of the disease process. Design: Retrospective case note analysis of outcome of those patients who needed norepinephrine according to our institutional regimen. Patients: A total of 100 consecutive patients admitted to our 31-bed medical-surgical intensive care unit (ICU) who were treated with norepinephrine for severe hypotension and evidence of end-organ hypoperfusion unresponsive to both fluid resuscitation and dopamine treatment at 20 μg/kg/min. Measurements: The degree of organ dysfunction at the time of starting norepinephrine treatment was assessed by the sequential organ failure assessment (SOFA) score. The time before starting norepinephrine treatment was defined as the time elapsed between ICU admission and that of starting norepinephrine administration. The patients were defined as survivors or nonsurvivors according to their ICU outcome. Results: There were relationships between mortality and the degree of organ dysfunction and mortality and the duration of ICU stay before starting norepinephrine treatment. The mortality rate was 100% in the 30 patients with a total SOFA score of >12 and a delay before starting norepinephrine treatment of >1 day. The mortality rate of the other patients was 63%. The lowest mortality was seen in patients with lower SOFA scores and early norepinephrine administration after admission. Conclusions: Both the time of starting norepinephrine treatment after admission to the ICU and the degree of organ dysfunction have an important bearing on subsequent outcome. Although norepinephrine may be a lifesaving catecholamine in some cases, its administration to patients who have already developed multiple organ failure during their stay in the ICU is associated with a poor outcome.Keywords
This publication has 21 references indexed in Scilit:
- Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care unitsCritical Care Medicine, 1998
- Influence of alterations in forgoing life-sustaining treatment practices on a clinical sepsis trialCritical Care Medicine, 1997
- Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsisIntensive Care Medicine, 1996
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Norepinephrine or Dopamine for the Treatment of Hyperdynamic Septic Shock?Chest, 1993
- Septic shock: a goal‐directed therapy using volume loading, dobutamine and/or norepinephrineActa Anaesthesiologica Scandinavica, 1990
- Renal effects of norepinephrine used to treat septic shock patientsCritical Care Medicine, 1990
- Terminal events in the intensive care unitCritical Care Medicine, 1989
- Reversal of intractable septic shock with norepinephrine therapyCritical Care Medicine, 1988
- Hemodynamic effects of continuous norepinephrine infusion in dogs with and without hyperkinetic endotoxic shockCritical Care Medicine, 1987